Nomura Asset Management Co. Ltd. Has $77.36 Million Position in CME Group Inc. $CME

Nomura Asset Management Co. Ltd. reduced its stake in shares of CME Group Inc. (NASDAQ:CME) by 13.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 283,274 shares of the financial services provider’s stock after selling 43,060 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in CME Group were worth $77,356,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Asset Dedication LLC grew its position in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new position in shares of CME Group during the 4th quarter worth about $27,000. Legacy Wealth Managment LLC ID grew its position in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the period. Global Wealth Strategies & Associates grew its position in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after buying an additional 100 shares during the period. Finally, Anfield Capital Management LLC grew its position in shares of CME Group by 197.4% during the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 75 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This represents a 31.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

Shares of CME opened at $273.54 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50 day simple moving average of $293.28 and a 200 day simple moving average of $289.51. CME Group Inc. has a 52-week low of $257.17 and a 52-week high of $329.16. The firm has a market capitalization of $99.12 billion, a PE ratio of 23.34, a P/E/G ratio of 3.06 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the firm earned $2.80 EPS. CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 44.37%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced that Chairman and CEO Terry Duffy will present at the Piper Sandler Global Exchange and Fintech Conference on June 4, which keeps the company visible to investors and may reinforce its growth story. Article Title
• Positive Sentiment: Recent coverage says CME’s planned 24/7 Bitcoin and Ethereum futures trading could attract more institutional crypto volume, which may support future derivatives activity and trading revenue. Article Title
• Neutral Sentiment: CME also lowered margin requirements on gold and silver futures, a move that may help keep trading active during volatile commodity markets but is not clearly a major fundamental catalyst. Article Title
• Neutral Sentiment: Macro commentary from the CME floor highlighted sticky inflation and stronger durable goods data, which could keep Fed policy uncertain and sustain trading activity, but the direct impact on CME stock is unclear. Article Title
• Negative Sentiment: Crypto articles suggesting Bitcoin’s “CME gap” may disappear with round-the-clock trading could reduce the market’s focus on CME-specific weekend price gaps, weakening one of the more visible trading narratives tied to the company’s crypto franchise. Article Title

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Jefferies Financial Group decreased their target price on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Keefe, Bruyette & Woods assumed coverage on CME Group in a research report on Wednesday, April 8th. They set a “market perform” rating and a $305.00 target price for the company. Raymond James Financial boosted their target price on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. Piper Sandler boosted their target price on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 15th. Finally, TD Cowen decreased their price objective on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $305.29.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.